<DOC>
	<DOCNO>NCT02805166</DOCNO>
	<brief_summary>The purpose study estimate safety efficacy PEG-rhG-CSF patient lung cancer , head neck cancer , colorectal cancer , ovarian cancer receive multi-cycle chemotherapy .</brief_summary>
	<brief_title>PEG-rhG-CSF Patients With Malignant Solid Tumors Receiving Chemotherapy</brief_title>
	<detailed_description />
	<mesh_term>Neoplasms</mesh_term>
	<criteria>Patients age ≥ 18 year diagnosis lung cancer , head neck cancer , colorectal cancer , ovarian cancer Karnofsky Performance Status ≥ 70 life expectancy least 3 month Written inform consent acquire uncontrolled infection , Temperature 38.0 ℃ high pregnancy Other situation investigator consider contraindication study</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>June 2016</verification_date>
	<keyword>PEG-rhG-CSF</keyword>
</DOC>